BRIEF-Titan Pharma receives FDA communication on ropinirole implant INDA
* Titan Pharmaceuticals receives FDA communication on ropinirole implant investigational new drug application
Jan 6 West Pharmaceutical Services Inc
* West Pharmaceutical Services - co and Daikyo Seiko entered amended and restated technology exchange and crosslicense agreement and two distributorship agreements
* West Pharmaceutical Services Inc says company maintains a 25 pct ownership interest in Daikyo
* West Pharmaceutical Services Inc says maintains a 25 pct ownership interest in Daikyo Source text: (bit.ly/2iR9K0Y) Further company coverage:
* TSX closes down 69.96 points, or 0.45 percent, at 15,463.51
Feb 27 Travel website operator Priceline Group Inc reported a 17.4 percent rise in fourth-quarter revenue, driven by higher hotel bookings.